ECSP003747A - METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES - Google Patents

METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES

Info

Publication number
ECSP003747A
ECSP003747A EC2000003747A ECSP003747A ECSP003747A EC SP003747 A ECSP003747 A EC SP003747A EC 2000003747 A EC2000003747 A EC 2000003747A EC SP003747 A ECSP003747 A EC SP003747A EC SP003747 A ECSP003747 A EC SP003747A
Authority
EC
Ecuador
Prior art keywords
treatment
compositions
pulmonary diseases
diseases
phosphodiesterase
Prior art date
Application number
EC2000003747A
Other languages
Spanish (es)
Inventor
Theodore Torphy
Richard Nieman
Peter GOODFELLOW
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ECSP003747A publication Critical patent/ECSP003747A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se refiere al tratamiento de enfermedades pulmonares tales como la enfermedad pulmonar obstructiva crónica o asma por medio de la administración de un inhibidor de la fosfodiesterasa 4 en combinación con un corticosteroide anti-inflamatorio.This invention relates to the treatment of pulmonary diseases such as chronic obstructive pulmonary disease or asthma by the administration of a phosphodiesterase 4 inhibitor in combination with an anti-inflammatory corticosteroid.

EC2000003747A 1999-11-02 2000-10-31 METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES ECSP003747A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
ECSP003747A true ECSP003747A (en) 2002-05-23

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003747A ECSP003747A (en) 1999-11-02 2000-10-31 METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (en) * 2001-09-19 2009-06-10 尼科梅德有限责任公司 Combination of a NSAID and a PDE-4 inhibitor
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (en) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
ES2702753T3 (en) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Inhalation device
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT710109E (en) * 1993-06-18 2005-01-31 Smithkline Beecham Corp METHOD FOR IDENTIFYING A PDE IV INHIBITOR
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
PE20011005A1 (en) 2001-09-28
CZ20021512A3 (en) 2003-04-16
ZA200203435B (en) 2003-06-25
MA26841A1 (en) 2004-12-20
DZ3225A1 (en) 2001-05-10
CA2388333A1 (en) 2001-05-10
EP1225866A2 (en) 2002-07-31
TR200201211T2 (en) 2002-08-21
KR20020057988A (en) 2002-07-12
AP2002002496A0 (en) 2002-06-30
NO20022057D0 (en) 2002-04-30
EA200200518A1 (en) 2002-10-31
OA12076A (en) 2006-05-04
JP2003513028A (en) 2003-04-08
AU1357501A (en) 2001-05-14
HK1049107A1 (en) 2003-05-02
PL355261A1 (en) 2004-04-05
WO2001032127A3 (en) 2001-12-06
MXPA02004350A (en) 2002-11-07
TWI242431B (en) 2005-11-01
CO5261512A1 (en) 2003-03-31
AR029189A1 (en) 2003-06-18
HUP0203152A3 (en) 2004-06-28
CN1387404A (en) 2002-12-25
HUP0203152A2 (en) 2003-01-28
NO20022057L (en) 2002-06-27
WO2001032127A2 (en) 2001-05-10
BG106748A (en) 2003-02-28
BR0015270A (en) 2002-06-18
IL149367A0 (en) 2002-11-10
EP1225866A4 (en) 2004-04-21
SK7592002A3 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
UY28958A1 (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
AR022072A1 (en) THERAPIES AND COMPOSITIONS TO TREAT PULMONARY DISEASES
CR7043A (en) DERIVATIVES OF USEFUL ETERES AS INHIBITING GANETS OF THE ISOZIMAS PDE4
WO2005073224A3 (en) Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
BR0107934A (en) Pyrimidine Carboxamides Useful as Inhibitors of pde4 Isozymes
MXPA03010487A (en) Diarylurea derivatives useful as anti-inflammatory agents.
MXPA04000793A (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma.
WO2004005279A3 (en) Substituted anthranilic amide derivatives and methods of use
WO2007005668A3 (en) Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
DOP2006000210A (en) AMIDA PYRIMIDINE COMPOUNDS AS PGDS INHIBITORS
BR0009446A (en) Compound, process for preparing the same, composition, use of a compound, and, methods for the treatment or prevention of a disease in a mammal, for the treatment or prevention of asthma in a mammal and for the treatment or prevention of disease chronic obstructive pulmonary disease in a mammal
WO2008057252A3 (en) Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
CR7038A (en) AMIDA DERIVATIVES OF TIAZOLILICO, OXAZOLILICO, PIRROLILICO AND IMIDIAZOLILICO ACIDS USED AS INHIBITORS OF THE ISOZIMAS PDE4
WO2005070891A3 (en) Compounds and methods of use
DK1819227T3 (en) Pharmaceutical formulation of decitabine
WO2006063111A3 (en) Pharmaceutical formulations cytidine analogs and derivatives
ECSP003747A (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
WO2005061467A3 (en) Piperazine derivatives as bradykinin antagonists
WO2003072593A3 (en) Bone targeting peptides
SE9900833D0 (en) Novel combination
BR0010546A (en) Anti-inflammatory therapy for inflammatory mediated infection
BR0008382A (en) Controlled release formulation for copd treatment
UY26423A1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
PA8683901A1 (en) AMIDAS REPLACED WITH HETEROARILO THAT INCLUDE A SATURATED LINKER GROUP, AND ITS USE AS PHARMACEUTICAL AGENTS
BRPI0516383A (en) cyclic sulfonyl amino derivatives and their use